(PDF) P2.01-39 Can Benefit or Futility in Treating Advanced

P2.01-39 Can Benefit or Futility in Treating Advanced NSCLC Be Determined Early Using the LCSS 3-Item Global Index (3-Igi) PRO?

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1093

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

Publisher

Elsevier BV

Related search

P2.01-050 Predicting Risk of Hospitalization in Patients With NSCLC Receiving Chemotherapy Using the LCSS 3-Item Global Index (3-Igi)

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-70 Tumor Treating Fields and Radiosurgery for Supra- And/or Infratentorial Brain Metastases (1-10) From NSCLC in the Phase 3 METIS Study

Journal of Thoracic Oncology

Respiratory Medicine

English

Efficient Vasculature Investment in Tissues Can Be Determined Without Global Information

Journal of the Royal Society Interface

Biomedical Engineering

English

P2.01-61 Body Mass Index Over Time Is Associated With Overall Survival in Advanced NSCLC Patients Treated With Immunotherapy.

Journal of Thoracic Oncology

Respiratory Medicine

English

Can Global Precipitation Datasets Benefit the Estimation of the Area to Be Cropped in Irrigated Agriculture?

English

266.�Human Endometrial Cycle Stages Can Be Determined by Global Gene Expression Profiling

Reproduction, Fertility and Development

Developmental Biology

Molecular Biology

Reproductive Medicine

English

P2.01-95 Assesment the Fitness for Chemotherapy of NSCLC Patients Using 6MWT

Journal of Thoracic Oncology

Respiratory Medicine

English

3 Advances in Treating Heart Failure

Postgraduate Medical Journal

English

To Be or Not to Be? (From Act 3, Scene 1 ofHamlet)

Methodist DeBakey cardiovascular journal

English